Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
(NASDAQ:CYTK), SOUTH SAN FRANCISCO, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on November 15, 2025 it granted stock options to purchase 87,297 restricted stock units (RSUs) that will be settled in shares of common stock upon vesting to Jeffrey Hessekiel, the Company's Executive Vice President, Chief Legal and […]